Erasca Inc (ERAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ERAS | FOLD | LGND | ||
| Company | Erasca Inc | Amicus Therapeutics | Ligand Pharm | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 13.38 | 14.37 | 207.43 | ||
| High | 13.88 | 14.38 | 211.00 | ||
| Low | 13.36 | 14.37 | 206.92 | ||
| Latest | 13.65 | 14.38 | 208.55 | ||
| Change | +0.15 | +0.01 | -0.97 | ||
| % Change | +1.11% | +0.07% | -0.46% | ||
| Volume | 2,535,092 | 1,078,835 | 47,399 | ||
| 20-Day Average Volume | 4,433,331 | 3,700,951 | 217,419 | ||
| Previous Close | 13.50 | 14.37 | 209.52 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 14.18 | 14.36 | 203.01 | ||
| 20-Day Raw Stochastic | 33.69% | 81.25% | 62.41% | ||
| 20-Day Relative Strength | 58.60 | 75.52 | 56.10 | ||
| Weighted Alpha | +522.01 | +65.15 | +89.71 | ||
| Today's Opinion | 80% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 80% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.24% since 03/12/26 | +0.03% since 03/12/26 | -0.97% since 03/12/26 | ||
| Low | 12.91 on 03/17/26 | 14.37 on 03/19/26 | 200.69 on 03/13/26 | ||
| High | 15.56 on 03/13/26 | 14.39 on 03/18/26 | 214.80 on 03/13/26 | ||
| 1-Month | |||||
| %Chg | +9.69% since 02/19/26 | +0.17% since 02/19/26 | +12.40% since 02/19/26 | ||
| Low | 12.16 on 02/20/26 | 14.31 on 02/20/26 | 178.72 on 02/26/26 | ||
| High | 16.41 on 03/10/26 | 14.39 on 03/18/26 | 227.92 on 03/11/26 | ||
| 3-Month | |||||
| %Chg | +293.91% since 12/19/25 | +1.38% since 12/19/25 | +4.54% since 12/19/25 | ||
| Low | 3.32 on 12/23/25 | 14.18 on 12/23/25 | 175.89 on 01/13/26 | ||
| High | 16.41 on 03/10/26 | 14.39 on 03/18/26 | 227.92 on 03/11/26 | ||
| 6-Month | |||||
| %Chg | +638.59% since 09/19/25 | +72.57% since 09/19/25 | +25.77% since 09/19/25 | ||
| Low | 1.75 on 09/23/25 | 7.68 on 10/01/25 | 163.45 on 09/25/25 | ||
| High | 16.41 on 03/10/26 | 14.39 on 03/18/26 | 227.92 on 03/11/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,195,800 | 4,512,195 | 4,178,036 | ||
| Shares Outstanding, K | 310,800 | 314,001 | 19,941 | ||
| Annual Sales | 0 | 634,210,000 | 268,090,000 | ||
| Annual Net Income | -124,550,000 | -27,110,000 | 124,450,000 | ||
| Last Quarter Sales | 0 | 185,210,000 | 59,670,000 | ||
| Last Quarter Net Income | -29,090,000 | 1,690,000 | 44,780,000 | ||
| 60-Month Beta | 1.16 | 0.43 | 1.17 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.10 on 03/12/26 | 0.10 on 02/20/26 | 2.02 on 02/26/26 | ||
| Latest Earnings Date | 05/12/26 | 05/07/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | 2.500 on 04/03/07 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 479.00 | 36.19 | ||